Our target potential upside is 4% to 15% in the next 3-6 months.
XP (NASDAQ: XP) Just Broke Out and Looks Ready for a Surge
by
•Our target potential upside is almost 15% to 31% in the next 4-6 months.
Get Ready to Buy Zoom (NASDAQ: ZM)
by
•With multiple bullish indicators, it looks ready to break through resistance.
Vontier (NYSE: VNT) Looks to be Gearing Up for a Surge
by
•Our target potential upside is nearly 13% to 27% in the next 3-6 months.
Macerich (NYSE: MAC) Finally Broke Out
by
•Our target potential upside is 22% to 68% in the next 3-5 months.
Occidental Petroleum (NYSE: OXY) Looks Poised for a Surge
by
•Our target potential upside is 18% to 54% in the next 3-6 months.
An Upmove May Be Imminent with Alnylam Pharmaceuticals (NASDAQ: ALNY)
by
•Our target potential upside is 4% to 23% in the next 4-6 months.
The Bulls Are in Control of Aldeyra Therapeutics (NASDAQ: ALDX)
by
•Our target potential upside is almost 33% to 120% in the next 3-6 months.
International Flavors & Fragrances (NYSE: IFF) Broke Out and Looks Ready For a Surge
by
•Our target potential upside is 6% to 12% in the next 4 to 6 months.
Smith & Wesson Brands (NASDAQ: SWBI) Just Broke Out
by
•Our target potential upside is 15% to 44% in the next 4-6 months.